| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/22/2011 | US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent |
| 02/22/2011 | US7893074 inhibition of focal adhesion kinase or/and IGF-1 Receptor; for example: 2-[2-(2,5-Dimethoxy-phenylamino)-5-nitro-pyrimidin-4-ylamino]-N-methyl-benzenesulfonamide |
| 02/22/2011 | US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic |
| 02/22/2011 | US7893068 Physiologically active substances |
| 02/22/2011 | US7893065 mitogen activated protein kinase inhibitors; 4-(2-Fluoro-4-(methylthio)phenylamino)-N-(2-hydroxyethoxy)-1-methyl-6-oxo-1,6-dihydropyridazine-3-carboxamide; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 02/22/2011 | US7892531 Human serum albumin(HSA); solubilized in low-ionic-strength buffer with specified ph; glycine, aspartic acid, sodium succinate, trehalose; binds with receptors |
| 02/22/2011 | CA2601515C Compounds having immunomodulator activity |
| 02/22/2011 | CA2533509C Piperidine compounds and pharmaceutical compositions containing them |
| 02/22/2011 | CA2476296C Amino-derivatives as inhibitors of histone deacetylase |
| 02/22/2011 | CA2470564C Recombinant polypeptides |
| 02/22/2011 | CA2463968C Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 02/22/2011 | CA2447712C Herbal drug composition for cartilage protection |
| 02/22/2011 | CA2446314C Liver x receptor agonists |
| 02/22/2011 | CA2411818C Cyclopentabenzofuran compounds and uses thereof |
| 02/22/2011 | CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds |
| 02/22/2011 | CA2398163C Therapeutic morpholino-substituted compounds |
| 02/17/2011 | WO2011020095A2 Compositions and methods of treating inflammation |
| 02/17/2011 | WO2011019780A1 Azaindazoles as btk kinase modulators and use thereof |
| 02/17/2011 | WO2011019045A1 Disintegrating particle composition and orally rapidly disintegrating tablet |
| 02/17/2011 | WO2011018902A1 Pharmaceutical composition for suppressing pain |
| 02/17/2011 | WO2011018510A1 New macrolides and their use |
| 02/17/2011 | WO2011018454A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
| 02/17/2011 | WO2011018417A1 Inhibitors of jnk |
| 02/17/2011 | WO2010123959A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 02/17/2011 | US20110040240 Methods for treating rhinitis and conjunctivitis |
| 02/17/2011 | US20110039939 Storage-stable formulation of paracetamol in aqueous solution |
| 02/17/2011 | US20110039938 Storage-stable formulation of paracetamol in aqueous solution |
| 02/17/2011 | US20110039936 N-Substituted Benzenepropanamide or Benzenepropenamide Derivatives for Use in the Treatment of Pain and Inflammation |
| 02/17/2011 | US20110039930 Fast-acting naproxen composition with reduced gastrointestinal effects |
| 02/17/2011 | US20110039928 Cetylated fatty acid and alkali buffered creatine anti-inflammatory composition |
| 02/17/2011 | US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients |
| 02/17/2011 | US20110039922 18beta-GLYCYRRHETINIC ACID DERIVATIVES AND SYNTHETIC METHOD THEREOF |
| 02/17/2011 | US20110039920 Inhibitors of ikk-beta serine-theronine protein kinase |
| 02/17/2011 | US20110039919 Pharmaceutical compositions for inhibiting angiogenesis |
| 02/17/2011 | US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 02/17/2011 | US20110039874 Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity |
| 02/17/2011 | US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii |
| 02/17/2011 | US20110039864 Therapeutic compounds |
| 02/17/2011 | US20110039862 Protease Inhibitors |
| 02/17/2011 | US20110039858 Novel Compounds |
| 02/17/2011 | US20110039848 Five-membered ring compound |
| 02/17/2011 | US20110039838 Pyrrolotriazine compounds as kinase inhibitors |
| 02/17/2011 | US20110039828 Tetrahydroquinoline derivatives and a process for preparing the same |
| 02/17/2011 | US20110039817 4-aminopyrimidine derivatives as histamine h4 receptor antagonists |
| 02/17/2011 | US20110039812 N-alkylcarbonyl-d-amino hydroxyalkyl ester compounds and their use |
| 02/17/2011 | US20110039808 Multitarget Compounds Active at a PPAR and Cannabinoid Receptor |
| 02/17/2011 | US20110039801 Nk1 receptor antagonist composition |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110039795 2'-o,3'-n-bridged macrolides |
| 02/17/2011 | US20110039791 Acetylcholinesterase (ache)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof |
| 02/17/2011 | US20110038965 Topical formulation and uses thereof |
| 02/17/2011 | US20110038962 Dietary supplements and methods for treating pain and inflammation |
| 02/17/2011 | US20110038956 Selenium-containing compositions and uses thereof |
| 02/17/2011 | US20110038955 Prevention of gastric ulcer by carbon monoxide |
| 02/17/2011 | US20110038953 Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/17/2011 | US20110038938 Compositions for tissue augmentation |
| 02/17/2011 | US20110038927 Controlled release hydrocodone formulations |
| 02/17/2011 | US20110038925 Intravenous formulations of neurokinin-1 antagonists |
| 02/17/2011 | US20110038920 Wound healing compositions and treatments |
| 02/17/2011 | US20110038918 Composition For Transdermal Delivery of Fentanyl |
| 02/17/2011 | US20110038903 Apparatus and Process for Generating and Harvesting Adult Stem Cells and Fluid Associated with it from Skin and Omentum for Medical, Cosmetic, and Veterinary Use |
| 02/17/2011 | US20110038893 Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038882 Methods for Treating Allergic Disease |
| 02/17/2011 | US20110038878 Antibodies to il-17a |
| 02/17/2011 | US20110038856 Methods of treating neoplastic, autoimmune and inflammatory diseases |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | CA2770873A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation |
| 02/17/2011 | CA2770583A1 Pharmaceutical composition for relieving pain |
| 02/17/2011 | CA2769551A1 New macrolides and their use |
| 02/17/2011 | CA2768749A1 Inhibitors of jnk |
| 02/16/2011 | EP2284209A1 Polymer conjugate of folic acid or folic acid derivative |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283898A1 Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283838A2 Docosahexaenoic acid for treating subclinical inflammation |
| 02/16/2011 | EP2283837A2 Docosahexaenoic acid for treating subclinical inflammation |
| 02/16/2011 | EP2283836A1 Anti-inflammatory creatine composition comprising a cetylated fatty acid |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283017A1 Fused pyrimidineone compounds as trpv3 modulators |
| 02/16/2011 | EP2283009A1 Inhibitors of jnk |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2282994A1 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor |
| 02/16/2011 | EP2282742A1 Inhibitors of fatty acid amide hydrolase |
| 02/16/2011 | EP2282729A1 Methods and compositions for treating inflammation and inflammation-related pathologies |
| 02/16/2011 | EP2046762B1 Triazolyl phenyl benzenesulfonamides |
| 02/16/2011 | EP1835021B1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/16/2011 | CN1931251B Analgesic medicine composition and its preparation process and application |
| 02/16/2011 | CN1814217B Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
| 02/16/2011 | CN101977945A Anti-microbial polymers and their compositions |
| 02/16/2011 | CN101977931A Polypeptide and pharmaceutical composition containing the polypeptide |
| 02/16/2011 | CN101977911A Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 02/16/2011 | CN101977910A N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |